A 373-share grant replaces director fees for Sumit Roy at Ventas (VTR).
Ventas, Inc. director Sumit Roy was granted 373 shares of common stock on October 1, 2026, as compensation in lieu of director fees through the Non-Employee Directors’ Cash Compensation Deferral Plan. The shares were valued at $83.73 each on the grant date, bringing his total direct holdings to 25,245 shares. This transaction was reported in a Form 4 SEC filing.
In lieu of director fees, Roxanne M. Martino receives 582 Ventas (VTR) stock units.
Ventas director Roxanne M. Martino received 582 common-stock units on October 1, 2026, as compensation in lieu of director fees under the Non-Employee Directors' Cash Compensation Deferral Plan. These units are payable solely in Ventas common stock, and her direct holdings after this grant totaled 67,428 shares. The closing price per share on the grant date was $83.73.
Director Matthew J. Lustig receives 447.868 stock units instead of fees at Ventas (VTR).
Matthew J. Lustig, a director at Ventas, Inc. (VTR), received 447.868 common-stock units on October 1, 2026. These units were granted under the Non-Employee Directors' Cash Compensation Deferral Plan in lieu of director fees, as per his deferral election. The reported grant-date closing price was $83.73 per share, and his direct holdings after this transaction totaled 96,183 shares.
In lieu of director fees, Maurice S. Smith receives 478 stock units from Ventas (VTR).
Ventas, Inc. director Maurice S. Smith received 478 common stock units on October 1, 2026, as part of a grant under the Non-Employee Directors' Cash Compensation Deferral Plan, in lieu of director fees. The units are payable in common stock, with a value based on the closing price of $83.73 per share on the grant date. Following this transaction, Smith's direct holdings in Ventas total 31,789 shares.
Ventas schedules third-quarter results and Ventas stock yields 2.48 percent
Ventas, Inc. is scheduled to release its third-quarter 2026 results on October 27, following a strong second quarter where revenue rose 21.70% and normalized funds from operations per share increased by 9.00%. The company has raised its full-year 2026 normalized FFO guidance and significantly increased its investment target, primarily driven by growth in its Senior Housing Operating Portfolio. Ventas stock, trading at EUR 75.03, offers a forward annual dividend yield of 2.48%, with analysts maintaining an Outperform rating.
Omega Healthcare Investors Inc. Research & Ratings | OHI
This article provides research and ratings for Omega Healthcare Investors Inc. (OHI), including analyst ratings, price targets, stock grader rating, and financial data such as EPS, P/E ratio, and dividend yield. It also details the company's business focus on financing and capital for the long-term healthcare industry and provides quarterly and yearly earnings estimates.
Press Release: National Healthcare Properties Announces Fourth Quarter 2026 Common Stock Dividend
National Healthcare Properties has announced its common stock dividend for the fourth quarter of 2026. This press release provides details on the dividend, including the amount and record date for shareholders.
NHI Announces $107.7 Million SHOP Investment
National Health Investors, Inc. (NHI) has announced a $107.7 million investment, including transaction costs, for the acquisition of six properties with 443 units across Kentucky, Michigan, and Tennessee. These properties will be part of NHI's Senior Housing Operating Portfolio (SHOP) and managed by Allegro Living Management. NHI expects these communities to generate an initial NOI yield of approximately 7.0%.
Ventas sets October 27 results date for Ventas stock
Ventas (NYSE: VTR) is scheduled to release its third-quarter 2026 results on October 27, 2026, after market close, followed by a conference call on October 28. The company previously raised its 2026 normalized FFO guidance due to strong senior housing investments and increased same-store cash net operating income. Investors will be looking to see if this positive momentum continues in the upcoming earnings report.
Ventas stock trades at EUR 76.20 as results date nears
Ventas Inc. stock is trading at EUR 76.20 as the company approaches its third-quarter 2026 earnings release on October 27. The healthcare REIT previously reported strong second-quarter results with USD 1.73 billion in revenue and normalized FFO of USD 0.97 per share, showing significant operating growth in its senior housing portfolio. Analysts maintain an "Outperform" rating, and Ventas has raised its full-year FFO guidance and senior housing investment target.
Ventas Inc To Go Ex-Dividend On September 30th, 2026 With 0.52 USD Dividend Per Share
Ventas Inc. (VTR) is scheduled to go ex-dividend on September 30th, 2026, with a dividend payment of $0.52 per share. Investors wishing to receive this dividend must own VTR shares before this date. This announcement is important for current and prospective shareholders interested in the company's dividend policy.
Exchange rate effect of Ventas, Inc. – HAN:VEN
This article focuses on the exchange rate effect related to Ventas, Inc. (HAN:VEN) as listed on the Hannover Stock Exchange. It indicates that there were no trades and the market was closed at the time of publication. The content also lists various financial data providers and legal disclaimers.
Ventas, Inc. Bonds — Corporate Bond Rates
This article provides a list of corporate bonds issued by Ventas, Inc. and Ventas Realty Limited Partnership, sorted by yield to worst. It includes details such as yield, price, coupon rate, maturity date, outstanding amount, face value, and S&P credit ratings for each bond. The information is presented for investors seeking stable investments during market volatility.
Ventas stock at USD 87.03 on September 28, 2026, up 0.51 percent
Ventas Inc. (NYSE: VTR) stock closed at USD 87.03 on September 28, 2026, marking a 0.51 percent increase. The company has scheduled its third-quarter 2026 results release for October 27, with a conference call the following day. Additionally, Ventas announced a quarterly dividend of USD 0.52 per common share, payable on October 15, 2026.
Ventas stock at USD 86.64 on September 25, 2026, down 0.22 percent
Ventas Inc. stock traded at USD 86.64 on September 25, 2026, marking a 0.22 percent decrease. The company is set to release its third-quarter 2026 earnings on October 27, with a conference call scheduled for October 28. Investors can access the earnings call via a live webcast on Ventas's investor-relations website.
What's in the Offing for Ventas Stock This Earnings Season?
Ventas, Inc. (VTR) is set to report its second-quarter 2026 results on July 29, with analysts expecting year-over-year growth in revenues and normalized FFO per share, driven by strong performance in its senior housing operating portfolio and outpatient medical research portfolio. The Zacks Consensus Estimate for Q2 revenues is $1.67 billion, a 17.36% increase from the prior year, and FFO per share is projected to be 96 cents, up 10.34%. However, the company's triple-net leased properties and high interest expenses might present challenges.
Welltower stock last at USD 230.05, down 1.52 percent in New York trading
Welltower Inc. (US95040Q1040) stock closed at USD 230.05 on September 25, 2026, marking a 1.52% decrease in New York trading, trailing the Nasdaq Composite which was up 0.48%. The session saw the stock trade between USD 229.88 and USD 237.32, with a trading volume of 804,235 shares. JPMorgan upgraded Welltower's rating from Neutral to Overweight on September 24, 2026.
DHCNI Bond Profile: Coupon and Redemption
This article provides a detailed profile of the Diversified Healthcare Trust (DHCNI) 5.625% Senior Notes due 2042 bond. It covers key facts about the issuer, bond classification, credit risk assessment, interest payment details, and redemption information. The bond profile is intended to help investors evaluate the potential and performance of this corporate bond.
Ventas stock heads into the open after a 0.17 percent gain
Ventas stock gained 0.17% to reach USD 86.79 on September 24, 2026, outperforming the S&P 500, which slipped less than 0.1%. Year-to-date, Ventas shares are up 14.08%. The article also mentions upcoming economic releases for the US market.
Ventas stock heads into the open after a 0.30 percent drop
Ventas stock experienced a 0.30 percent drop, closing at USD 86.60 on September 23, 2026, outperforming the S&P 500, which fell by 0.75 percent. The stock traded within a range of USD 86.40 to USD 87.18 and is set for a quarterly dividend of USD 0.52 per share with an ex-dividend date of September 30, 2026. Higher Treasury yields and stronger business activity data influenced the broader market.
Andra AP fonden Acquires 106,902 Shares of Ventas, Inc. $VTR
Andra AP fonden significantly increased its stake in Ventas, Inc. (NYSE:VTR) by 514.0% in the second quarter, acquiring an additional 106,902 shares. This brings their total holdings to 127,700 shares, valued at $11.34 million. Other institutional investors have also adjusted their positions in the real estate investment trust, which reported strong second-quarter earnings, beating analyst expectations and showing a 21.7% revenue increase year-over-year.
Why Ventas (VTR) is a Top Dividend Stock for Your Portfolio
Ventas (VTR) is highlighted as a top dividend stock due to its consistent cash flow generation and attractive dividend yield of 2.37%, surpassing the S&P 500. The company has increased its dividend by 8.3% from the previous year, and its payout ratio stands at 57% of trailing 12-month EPS. With an expected earnings growth rate of 11.78% for 2026 and a Zacks Rank of #3 (Hold), VTR presents a compelling opportunity for income investors despite potential interest rate sensitivities.
Baron Capital Maintains Outlook on Ventas (VTR)
Ventas, Inc. reported strong Q2 2026 results, with significant year-over-year increases in Net Operating Income and Normalized FFO per share, exceeding analyst expectations. The company is strategically focused on expanding its senior housing investments, raising its full-year 2026 investment volume expectations to $4.5 billion, and maintaining a strong balance sheet. Baron Capital has maintained its position in Ventas, citing expectations of per-share growth and the company's focus on senior housing.
Ventas Inc. stock gains 0.4 percent ahead of the open
Ventas Inc. stock rose 0.4% ahead of the open, closing at USD 87.03 on September 21, 2026, slightly underperforming the S&P 500. The company announced a USD 0.52 cash dividend with an ex-dividend date of September 30, 2026, and its next earnings report is scheduled for October 28, 2026. Evercore ISI maintained an Outperform rating but lowered its price target to USD 100.
Ventas: Investment-Grade Senior And Outpatient REIT, A Bet On Quality And Growth (VTR)
Ventas (VTR) is highlighted as an investment-grade senior and outpatient REIT with a strong growth thesis, supported by consistent earnings beats and positive FFO trends. The company boasts a geographically diverse portfolio and robust dividend coverage. While risks like operator concentration and valuation exist, the potential for upside and outperformance justifies a bullish stance.
Baron Capital Maintains Outlook on Ventas (VTR)
Baron Capital has maintained its positive outlook on Ventas (VTR) following the company's strong second-quarter 2026 results, which demonstrated accelerating operational momentum and strategic capital redeployment. Ventas reported significant year-over-year increases in Net Operating Income and Normalized FFO, driven by robust performance in its senior housing segment. The company also raised its full-year 2026 investment volume expectations, primarily focusing on accretive senior housing acquisitions.
Nykredit A S Makes New Investment in Ventas, Inc. $VTR
Nykredit A/S recently acquired 131,738 shares of Ventas, Inc. (NYSE:VTR) worth $11.7 million, making a new investment in the healthcare REIT. Ventas exceeded Q2 earnings expectations with $0.97 EPS and $1.73 billion in revenue, up 21.7% year-over-year. The company declared a quarterly dividend of $0.52 per share and has a "Moderate Buy" consensus rating from analysts with an average price target of $99.11.
Ventas Inc. stock edges lower as dividend and earnings support long-term gains
Ventas Inc. stock closed at USD 86.69 on September 18, 2026, trading about 14% below its 52-week high despite a consensus "Moderate Buy" rating from analysts with an average price target of USD 99.11. The healthcare REIT reported strong Q2 2026 earnings, beating analyst estimates, and offers a forward dividend yield of 2.37%. Ventas has also significantly outpaced the S&P 500 over various timeframes, driven by its exposure to aging demographics and healthcare real estate.
Ventas Stock: Is VTR Outperforming the Real Estate Sector?
Ventas, Inc. (VTR), a healthcare real estate investment trust with a market cap of $45.2 billion, has shown strong performance, outpacing the broader real estate sector (XLRE) over both three months and 52 weeks. The company recently reported better-than-expected Q2 2026 earnings, and analysts currently rate the stock as a "Strong Buy" with significant upside potential.
CareTrust REIT (CTRE) Stock May Be Undervalued After Skilled Nursing Deal
CareTrust REIT's stock has performed strongly, raising questions about its current valuation after recent acquisitions. Despite a P/E ratio above its industry average, a fair-value framework suggests the stock may be undervalued. The debate among investors and analysts centers on whether recent deals justify the current earnings-based valuation and future growth potential.
Omega Healthcare Investors (OHI) Could Be 9% Below Fair Value Following The Latest Fed Move
Omega Healthcare Investors (OHI) is gaining investor attention following the Federal Reserve's rate hike, with its share price at US$47.37. The company is considered 9% undervalued by many, with a fair value estimated at $51.94, driven by its dividend yield and management of its balance sheet. However, potential risks like tenant credit setbacks or cuts to Medicare/Medicaid reimbursements could challenge this valuation.
Goldman Sachs Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $112
Goldman Sachs has reiterated its Buy rating for Ventas Inc (VTR.US) and increased its target price to $112. This revision reflects the firm's continued positive outlook on the company's stock performance.
Janus Living Announces Closing of Upsized $1.25 Billion Revolving Credit Facility
Janus Living, a senior housing REIT, has closed an upsized $1.25 billion unsecured revolving credit facility, more than doubling its previous capacity from $600 million. This move extends debt maturity and provides substantial borrowing headroom, positioning the company for accretive external growth opportunities. The facility was undrawn at closing, indicating a strong balance sheet.
Ventas, Inc. $VTR Shares Purchased by Corient Private Wealth LP
Corient Private Wealth LP significantly increased its stake in Ventas, Inc. (NYSE:VTR) by 114.8% during the second quarter, bringing its total holdings to $15.13 million. This comes as other large institutional investors also adjusted their positions, and several Wall Street analysts have issued "Buy" or "Outperform" ratings for the real estate investment trust, with a consensus target price of $99.11. Ventas recently reported earnings that topped analyst estimates and declared a quarterly dividend.
Bank of America Corp DE Makes New $390.39 Million Investment in Ventas, Inc. $VTR
Bank of America Corp DE has made a significant new investment of $390.39 million in Ventas, Inc. (NYSE:VTR), acquiring approximately 0.86% of the healthcare REIT. This move comes as Ventas continues to perform well, exceeding quarterly earnings and revenue expectations, and maintaining a "Moderate Buy" consensus rating from analysts. The company also declared a quarterly dividend of $0.52, highlighting its financial health and appeal to institutional investors.
Ventas, Inc. Announces Appointment of Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, Effective on or About October 5, 2026
Ventas, Inc. has announced the appointment of Laurida Sayed as its Senior Vice President, Chief Accounting Officer, and Controller, effective around October 5, 2026. Ms. Sayed previously served as Chief Accounting Officer at Cushman & Wakefield Ltd. and brings extensive experience in global corporate control and finance transformation. She is a Certified Public Accountant with a Bachelor of Business Administration in Accounting.
Ventas, Inc. (NYSE:VTR) Announces $0.52 Quarterly Dividend
Ventas, Inc. (NYSE:VTR) has declared a quarterly dividend of $0.52 per share, payable on October 15th to shareholders of record on September 30th. While the current payout ratio of 270.1% suggests the dividend isn't fully covered by current earnings, analysts anticipate a future payout ratio of 48.5% based on next year's earnings. The company recently exceeded revenue and EPS estimates, and analysts maintain a "Moderate Buy" rating with an average price target of $99.00.
Ventas Declares Quarterly Dividend of $0.52 Per Common Share
Ventas, Inc. (NYSE: VTR) announced that its Board of Directors has declared a quarterly dividend of $0.52 per common share. The dividend will be paid on October 15, 2026, to stockholders of record as of September 30, 2026. Ventas is an S&P 500 company with approximately 1,450 properties, primarily focused on senior housing, outpatient medical buildings, research centers, and healthcare facilities.
Ventas, Inc. $VTR Shares Bought by Baird Financial Group Inc.
Baird Financial Group Inc. significantly increased its stake in Ventas, Inc. (NYSE:VTR) by 39.8% in the second quarter, adding 64,687 shares to own 227,174 shares valued at $20.2 million. Ventas, a real estate investment trust focused on healthcare properties, reported strong quarterly earnings, beating analyst expectations with adjusted EPS of $0.97 and revenue of $1.73 billion, a 21.7% year-over-year increase. Analysts maintain a "Moderate Buy" rating for VTR, with an average price target of $99.00, suggesting potential upside from its current trading price of $90.10.
HighTower Advisors LLC Has $5.10 Million Holdings in Ventas, Inc. $VTR
HighTower Advisors LLC reduced its stake in Ventas, Inc. by 29.4% in the second quarter, bringing its total holdings to $5.10 million. Despite this reduction, Ventas continues to see significant institutional investment, with 94.18% of its stock owned by institutional investors and hedge funds. Analyst ratings for Ventas are largely positive, with a consensus "Moderate Buy" rating and an average price target of $99.00.
Ventas Acquires Sierra Del Sol Senior Living in Tucson for $14.96 Million
Ventas, Inc., a prominent healthcare REIT, has acquired the Sierra Del Sol Assisted Living | Memory Care and Respite Care facility in Tucson, Arizona, for $14.96 million. The property, with 135 units and 140 beds, was purchased from an affiliate of Kohlberg Kravis Roberts & Co. This acquisition expands Ventas's healthcare real estate portfolio and represents a significant increase in value from its previous sale in 2018.
National Healthcare Properties Completes Sale of 30 Multi-Tenant OMFs for $198 Million
National Healthcare Properties (NHP) has completed the first phase of its sale of 86 outpatient medical facilities (OMFs), selling 30 properties for $198 million. This transaction generated $79 million in net cash proceeds after repaying $119 million in secured loans. The remaining 56 OMFs are expected to close in Q4 2026, with the buyer assuming approximately $220 million in secured debt.
Ventas, Inc. $VTR Shares Sold by Engineers Gate Manager LP
Engineers Gate Manager LP significantly reduced its stake in Ventas, Inc. (NYSE:VTR) by 72.2% during the second quarter, selling 536,068 shares. Despite this, other hedge funds like Angeles Wealth Management LLC and IHT Wealth Management LLC increased their holdings in the real estate investment trust. Ventas shares opened at $89.37, with a market capitalization of $45.84 billion and analysts maintaining a "Moderate Buy" rating with an average target price of $99.00.
California State Teachers Retirement System Grows Stock Holdings in Ventas, Inc. $VTR
The California State Teachers Retirement System significantly increased its stake in Ventas, Inc. by 9,549.4% in the second quarter, now holding 65.4 million shares valued at approximately $5.8 billion. Ventas reported strong Q2 earnings, beating analyst estimates with $0.97 EPS and revenue of $1.73 billion, up 21.7% year-over-year. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $99, indicating potential upside from its current share price.
Ventas, Inc. acquired Arbor Village from KKR & Co. Inc. for $24.1 million.
Ventas, Inc. acquired Arbor Village from KKR & Co. Inc. for $24.1 million on September 9, 2026. This valuation is based on industry speculation from excise tax affidavit records in King County. The transaction involved a cash consideration of $24.08 million.
Concurrent Investment Advisors LLC Buys 26,925 Shares of Ventas, Inc. $VTR
Concurrent Investment Advisors LLC significantly increased its stake in Ventas, Inc. (NYSE:VTR) by 737.3% in the second quarter, now owning 30,577 shares valued at $2.715 million. This move comes as several other institutional investors also adjusted their holdings in the real estate investment trust, which has seen positive analyst ratings and an average price target of $99.00. Ventas reported strong quarterly earnings, beating consensus estimates, and boasts a market capitalization of $46.13 billion.
Ventas, Inc. $VTR Stake Boosted by Amundi
Amundi increased its stake in Ventas, Inc. (NYSE:VTR) by 7.3% during the second quarter, now owning 1.78 million shares valued at approximately $158.3 million. Institutional investors collectively hold 94.18% of the healthcare REIT's stock. Analysts maintain a "Moderate Buy" consensus with an average price target of $99, following Ventas exceeding quarterly expectations with adjusted earnings of $0.97 per share and a 21.7% year-over-year revenue increase to $1.73 billion.
How Ardent Health uses joint ventures to grow
Ardent Health, a private equity-backed hospital operator, utilizes joint ventures with nonprofit and academic health systems as a core strategy for expansion. These partnerships allow Ardent to capitalize on localized opportunities, leverage partners' brand recognition and clinical specialists, and gain management fees and cash distributions, while the partners benefit from Ardent's operational expertise and access to capital. The model is presented as mutually beneficial, driving growth for Ardent and improving efficiency and reach for the joint venture partners.
Louisville health care and political giant Bruce Lunsford dies at 78
Bruce Lunsford, a prominent figure in Kentucky's healthcare and political landscape, has passed away at the age of 78. He was known for building Vencor into a leading long-term healthcare provider and founding Ventas Inc. Lunsford also served as Kentucky's first secretary of commerce.
VIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in Ventas, Inc. $VTR
Virginia Retirement Systems initiated a new position in Ventas, Inc. (NYSE:VTR) during the second quarter, purchasing 194,187 shares valued at approximately $17.2 million. Institutional investors now collectively own 94.18% of the healthcare REIT, with other large investors also significantly increasing their stakes. Ventas reported strong Q2 earnings, beating estimates, and analysts maintain a "Moderate Buy" rating with an average price target of $99.00.
